A reply to Dr Davis and other correspondents

Human S . Prophylactic gastroprotection for palliative care patients taking NSAIDs: an audit (Letter) . Palliat Med 2004; 18: 738–738 .

Shah S , Thomas B . Non-steroidal anti-inflammatory analgesics and gastrointestinal protection in palliative care patients (Letter) . Palliat Med 2004; 18: 739–740 .

Dickman A , Ellershaw J . NSAIDs: gastroprotection or selective COX-2 inhibitor? Palliat Med 2004; 18: 275–286 .

Field MJ , Lohr KN eds. Guidelines for clinical practice: from development to use. Washington National Academy Press , 1992.

Klein WW . Current and future relevance of guidelines . Heart 2002; 87: 497–500 .

Hurwitz B . Clinical guidelines and the law: negligence, discretion and judgement. Oxford: Radcliffe Medical Press , 1998.

http://www.rheumatology.org/annual/press/APPROVesession_annouce.pdf.Accessed23November2004.

Hanks G , Hawkins C . The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs. A review of the literature . J Pain Symptom Manage 2000; 2: 140–151 .

Catella-Lawson F , Reilly MP , Kapoor SC , et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin . N Engl J Med 2001; 345: 1809–1817 .

Silverstein FE , Faich G , Goldstein JL , et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal antiinflammatory drugs for osteoarthritis and rheumatoid arthritis . JAMA 2000; 284: 1247–1255 .

http://www.mhra.gov.uk/news/2004/celecoxibhealthlink201204doc.pdf. Accessed 21 December 2004.

http://www.bloomberg.com/apps/news?pid_10000103&sid_acJEZCSi1KNM&refer_us.Accessed21December 2004.

Tong R . The epistemology and ethics of consensus: uses and misuses of ‘ethical’ expertise . J Med Philosophy 1991; 16: 409–426 .